These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8634753)
21. Simple reversed-phase ion-pair liquid chromatography assay for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urine. Yau WP; Vathsala A; Lou HX; Chan E J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(1):101-12. PubMed ID: 15113545 [TBL] [Abstract][Full Text] [Related]
22. A simple HPLC method for monitoring mycophenolic acid and its glucuronidated metabolite in transplant recipients. Seebacher G; Weigel G; Wolner E; Mallinger R; Grimm M; Laufer G; El Menyawi I; Griesmacher A; Müller MM Clin Chem Lab Med; 1999 Apr; 37(4):409-15. PubMed ID: 10369111 [TBL] [Abstract][Full Text] [Related]
23. Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine. Benoit-Biancamano MO; Caron P; Lévesque E; Delage R; Couture F; Guillemette C J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):159-67. PubMed ID: 17827076 [TBL] [Abstract][Full Text] [Related]
24. Simultaneous determination of mycophenolic acid and its glucuronide and glycoside derivatives in canine and feline plasma by UHPLC-UV. Rivera SM; Hwang JK; Slovak JE; Court MH; Villarino NF Biomed Chromatogr; 2017 Aug; 31(8):. PubMed ID: 28146301 [TBL] [Abstract][Full Text] [Related]
25. Simultaneous determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human serum by capillary zone electrophoresis. Ohyama K; Kishikawa N; Nakagawa H; Kuroda N; Nishikido M; Teshima M; To H; Kitahara T; Sasaki H J Pharm Biomed Anal; 2008 May; 47(1):201-6. PubMed ID: 18262745 [TBL] [Abstract][Full Text] [Related]
26. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil. Morissette P; Albert C; Busque S; St-Louis G; Vinet B Ther Drug Monit; 2001 Oct; 23(5):520-5. PubMed ID: 11591897 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure. MacPhee IA; Spreafico S; Bewick M; Davis C; Eastwood JB; Johnston A; Lee T; Holt DW Kidney Int; 2000 Mar; 57(3):1164-8. PubMed ID: 10720968 [TBL] [Abstract][Full Text] [Related]
28. Liquid chromatographic method for simultaneous determination of mycophenolic acid and its phenol- and acylglucuronide metabolites in plasma. Khoschsorur G; Erwa W J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(2):355-60. PubMed ID: 14670756 [TBL] [Abstract][Full Text] [Related]
29. Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. Atcheson B; Taylor PJ; Mudge DW; Johnson DW; Pillans PI; Tett SE J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(1):157-63. PubMed ID: 14659448 [TBL] [Abstract][Full Text] [Related]
30. Simultaneous determination of mycophenolic acid and its metabolites by HPLC and pharmacokinetic studies in rat plasma and bile. Gao JW; Peng ZH; Li XY; Sun B; Guo YK; Liu GL Arch Pharm Res; 2011 Jan; 34(1):59-69. PubMed ID: 21468916 [TBL] [Abstract][Full Text] [Related]
31. Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites. Brandhorst G; Streit F; Goetze S; Oellerich M; Armstrong VW Clin Chem; 2006 Oct; 52(10):1962-4. PubMed ID: 16931568 [TBL] [Abstract][Full Text] [Related]
32. Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants. Ceglarek U; Casetta B; Lembcke J; Baumann S; Fiedler GM; Thiery J Clin Chim Acta; 2006 Nov; 373(1-2):168-71. PubMed ID: 16806142 [TBL] [Abstract][Full Text] [Related]
33. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation. Naito T; Shinno K; Maeda T; Kagawa Y; Hashimoto H; Otsuka A; Takayama T; Ushiyama T; Suzuki K; Ozono S Biol Pharm Bull; 2006 Feb; 29(2):275-80. PubMed ID: 16462031 [TBL] [Abstract][Full Text] [Related]
34. Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil. Jain AB; Hamad I; Zuckerman S; Zhang S; Warty VS; Fung JJ; Venkataramanan R Liver Transpl Surg; 1999 Mar; 5(2):101-6. PubMed ID: 10071348 [TBL] [Abstract][Full Text] [Related]
35. Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay. Kuhn J; Prante C; Kleesiek K; Götting C Clin Biochem; 2009 Jan; 42(1-2):83-90. PubMed ID: 18996104 [TBL] [Abstract][Full Text] [Related]
36. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients. Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513 [TBL] [Abstract][Full Text] [Related]
37. An isocratic high performance liquid chromatographic method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid-liquid extraction: application to human pharmacokinetic studies. Bahrami G; Mohammadi B Clin Chim Acta; 2006 Aug; 370(1-2):185-90. PubMed ID: 16707117 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients. Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients. Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M; Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631 [TBL] [Abstract][Full Text] [Related]
40. Relationship between MPA free fraction and free MPAG concentrations in heart transplant recipients based on simultaneous HPLC quantification of the target compounds in human plasma. Cussonneau X; Bolon-Larger M; Prunet-Spano C; Bastien O; Boulieu R J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):674-8. PubMed ID: 17350903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]